(19)
(11) EP 0 784 489 A2

(12)

(43) Date of publication:
23.07.1997 Bulletin 1997/30

(21) Application number: 95934027.0

(22) Date of filing: 20.10.1995
(51) International Patent Classification (IPC): 
G01N 33/ 566( . )
A61K 31/ 7042( . )
A61K 31/ 7064( . )
A61K 38/ 45( . )
A61K 49/ 04( . )
A61K 51/ 04( . )
C07H 19/ 073( . )
A61K 31/ 70( . )
A61K 31/ 7052( . )
A61K 31/ 7072( . )
A61K 48/ 00( . )
A61K 51/ 00( . )
C07H 19/ 067( . )
(86) International application number:
PCT/CA1995/000593
(87) International publication number:
WO 1996/012508 (02.05.1996 Gazette 1996/20)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI NL PT SE

(30) Priority: 21.10.1994 GB 19940021223

(71) Applicant: THE GOVERNORS OF THE UNIVERSITY OF ALBERTA
Edmonton, Alberta T6G 2E1 (CA)

(72) Inventors:
  • KNAUS, Edward E.
    Edmonton, Alberta T6J 2K2 (CA)
  • WIEBE, Leonard I.
    Edmonton, Alberta T6G 0W6 (CA)
  • MORIN, Kevin
    Edmonton, Alberta T5L 1E4 (CA)

(74) Representative: Ouzman, Beverley Nicola Claire, et al 
Murgitroyd and Company, 373 Scotland Street
Glasgow G5 8QA
Glasgow G5 8QA (GB)

   


(54) COMPOSITION USE OF NUCLEOSIDE ANALOGUES AND GENE TRANSFECTION FOR TISSUE IMAGING AND THERAPY